Selected article for: "liver aminotransferase and logistic regression"
Author: Kaneko, Shun; Kurosaki, Masayuki; Nagata, Kaoru; Taki, Reiko; Ueda, Ken; Hanada, Satoko; Takayama, Koji; Suzaki, Shinichiro; Harada, Naoshige; Sugiyama, Toru; Nagasawa, Masayuki; Izumi, Namiki
Title: Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity
  • Cord-id: r6z1gfy4
  • Document date: 2020_11_4
    • ID: r6z1gfy4
    Snippet: BACKGROUND/AIM: The coronavirus disease 2019 (COVID-19) had become a big threat worldwide. Liver injury is not uncommon in patients with COVID-19, and clarifying its characteristics is needed. This study aimed to identify factors associated with liver injury and to develop a new classification of predictive severity in patients with COVID-19. METHODS: Confirmed patients with COVID-19 (n = 60) were recruited retrospectively from Musashino Red Cross Hospital. The factors of liver injury especially
    Document: BACKGROUND/AIM: The coronavirus disease 2019 (COVID-19) had become a big threat worldwide. Liver injury is not uncommon in patients with COVID-19, and clarifying its characteristics is needed. This study aimed to identify factors associated with liver injury and to develop a new classification of predictive severity in patients with COVID-19. METHODS: Confirmed patients with COVID-19 (n = 60) were recruited retrospectively from Musashino Red Cross Hospital. The factors of liver injury especially on the elevation of liver enzymes (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) were analyzed. Grading was assessed according to the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. RESULTS: During a median hospitalization follow-up of 15 (4–41) days, 51 (85.0%) patients had COVID-19 pneumonia. In clinical courses, oxygenation was needed for 25 (41.6%) patients and intubation was needed for 9 (15.0%) patients. A total of 27 (45.0%) patients had gastrointestinal symptoms (GS), such as appetite loss, diarrhea, and nausea. A logistic regression analysis revealed that C-reactive protein (CRP) at baseline, oxygenation, intubation, and GS were significant factors of liver injury. Based on these results, patients were classified into three groups: group 1, no oxygenation pneumonia; group 2, pneumonia with oxygenation or GS; and group 3, intubation. We classified 25 (41.7%), 26 (43.3%), and 9 (15.0%) patients into mild, moderate, and severe groups, respectively. The peak of AST and ALT levels was significantly stratified with this criteria (mild [median AST, 28 IU/L; median ALT, 33 IU/L], moderate [median AST, 48 IU/L; median ALT, 47.5 IU/L], and severe [median AST, 109 IU/L; median ALT, 106 IU/L]; P<0.001 and P = 0.0114, respectively). CONCLUSION: COVID-19-related liver injury was significantly stratified based on GS and severity of pneumonia.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver and admission alt: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • abnormal liver and admission ast: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • abnormal liver and liver biopsy: 1, 2, 3, 4, 5, 6, 7
    • abnormal liver and liver disorder: 1
    • abnormal liver and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abnormal liver and liver enzyme elevation: 1
    • abnormal liver function and acute cardiac injury: 1, 2
    • abnormal liver function and admission alt: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal liver function and admission ast: 1, 2, 3, 4, 5
    • abnormal liver function and liver biopsy: 1, 2
    • abnormal liver function and liver disorder: 1
    • abnormal liver function and liver enzyme: 1, 2, 3, 4, 5, 6
    • acute cardiac injury and admission point: 1
    • acute cardiac injury and liver enzyme: 1
    • acute cardiac injury and liver enzyme elevation: 1
    • admission alt and liver enzyme: 1, 2
    • admission alt and liver enzyme elevation: 1
    • admission ast and liver enzyme: 1, 2, 3, 4
    • admission ast and liver enzyme elevation: 1